DelveInsight's 'Weight Loss/Weight Management (Obesity) - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Weight Loss/Weight Management (Obesity) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Study Period: 2017-2030
The DelveInsight Weight Loss/Weight Management (Obesity) epidemiology report gives a thorough understanding of the Weight Loss/Weight Management (Obesity) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Weight Loss/Weight Management (Obesity) in the US, Europe, and Japan. The report covers the detailed information of the Weight Loss/Weight Management (Obesity) epidemiology scenario in seven major countries (US, EU5, and Japan).
The Weight Loss/Weight Management (Obesity) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Weight Loss/Weight Management (Obesity) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Weight Loss/Weight Management (Obesity) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
The Weight Loss/Weight Management (Obesity) epidemiology covered in the report provides historical as well as forecasted Weight Loss/Weight Management (Obesity) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.
The DelveInsight Weight Loss/Weight Management (Obesity) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
1. Key Insights
2. Executive Summary of Weight Loss/Weight Management (Obesity)
3. Weight Loss/Weight Management (Obesity): Disease Background and Overview
3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis
4. Patient Journey
5. Epidemiology and Patient Population
5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
5.3.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in the 7MM (2017- 2030)
5.4. United States Epidemiology
5.4.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in the United States (2017- 2030)
5.5. EU-5 Country-wise Epidemiology
5.5.1. Germany Epidemiology
5.5.1.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in Germany (2017- 2030)
5.5.2. France Epidemiology
5.5.2.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in France (2017- 2030)
5.5.3. Italy Epidemiology
5.5.3.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in Italy (2017- 2030)
5.5.4. Spain Epidemiology
5.5.4.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in Spain (2017- 2030)
5.5.5. United Kingdom Epidemiology
5.5.5.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in the United Kingdom (2017-2030)
5.6. Japan Epidemiology
5.6.1. Weight Loss/Weight Management (Obesity) Epidemiology Scenario in Japan (2017- 2030)
6. Treatment Algorithm, Current Treatment, and Medical Practices
6.1. Weight Loss/Weight Management (Obesity) Treatment and Management
6.2. Weight Loss/Weight Management (Obesity) Treatment Algorithm
7. KOL Views
8. Unmet Needs
9. Appendix
9.1. Bibliography
9.2. Report Methodology
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
*The table of contents is not exhaustive; will be provided in the final report
Table 1 Weight Loss/Weight Management (Obesity) Epidemiology in 7MM (2017-2030)
Table 2 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in 7MM (2017-2030)
Table 3 Weight Loss/Weight Management (Obesity) Epidemiology in the United States (2017-2030)
Table 4 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in the United States (2017-2030)
Table 5 Weight Loss/Weight Management (Obesity) Epidemiology in Germany (2017-2030)
Table 6 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Germany (2017-2030)
Table 7 Weight Loss/Weight Management (Obesity) Epidemiology in France (2017-2030)
Table 8 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in France (2017-2030)
Table 9 Weight Loss/Weight Management (Obesity) Epidemiology in Italy (2017-2030)
Table 10 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Italy (2017-2030)
Table 11 Weight Loss/Weight Management (Obesity) Epidemiology in Spain (2017-2030)
Table 12 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Spain (2017-2030)
Table 13 Weight Loss/Weight Management (Obesity) Epidemiology in the United Kingdom (2017-2030)
Table 14 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
Table 15 Weight Loss/Weight Management (Obesity) Epidemiology in Japan (2017-2030)
Table 16 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Japan (2017-2030)
Figure 1 Weight Loss/Weight Management (Obesity) Epidemiology in 7MM (2017-2030)
Figure 2 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in 7MM (2017-2030)
Figure 3 Weight Loss/Weight Management (Obesity) Epidemiology in the United States (2017-2030)
Figure 4 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in the United States (2017-2030)
Figure 5 Weight Loss/Weight Management (Obesity) Epidemiology in Germany (2017-2030)
Figure 6 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Germany (2017-2030)
Figure 7 Weight Loss/Weight Management (Obesity) Epidemiology in France (2017-2030)
Figure 8 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in France (2017-2030)
Figure 9 Weight Loss/Weight Management (Obesity) Epidemiology in Italy (2017-2030)
Figure 10 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Italy (2017-2030)
Figure 11 Weight Loss/Weight Management (Obesity) Epidemiology in Spain (2017-2030)
Figure 12 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Spain (2017-2030)
Figure 13 Weight Loss/Weight Management (Obesity) Epidemiology in the United Kingdom (2017-2030)
Figure 14 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
Figure 15 Weight Loss/Weight Management (Obesity) Epidemiology in Japan (2017-2030)
Figure 16 Weight Loss/Weight Management (Obesity) Diagnosed and Treatable Cases in Japan (2017-2030)
*The table of contents is not exhaustive; will be provided in the final report
